RESUMO: "Outras plantas medicinais e produtos botânicos da 1ª Edição da Farmacopéia Brasileira". Em trabalho anterior foi descrita a relação das plantas medicinais e produtos botânicos presentes nas quatro edições da Farmacopéia Brasileira (FBRAS). O trabalho discutiu também sobre a substituição das plantas nativas do Brasil por outros produtos importados e sintéticos ao longo das últimas décadas. Neste artigo, são apresentados novos dados sobre plantas medicinais e produtos botânicos presentes na 1ª Edição da FBRAS e em seus dois suplementos.
INTRODUCTION
In a previous study we presented a list of the medicinal plants and other botanical products described in the four Editions of the Brazilian Offi cial Pharmacopoeia (FBRAS) (Brandão et al., 2006) . The work indicated the monographs which describe data concerning intact or pulverized vegetal drugs, as well as the fi rst products obtained from their extraction, as for example, tinctures, fl uid extracts, oils, resins, essential oils and balsams That paper also analyses the transformations within the Pharmacopoeia, focusing on the presence of monographs for native medicinal plants.
In this study, new informations were extracted from the 1 st Edition of FBRAS (Silva, 1929) and were organized in order to simplify its use. The informations present in two supplements, which were published later, were also included. The objective of these studies is to orient researchers in verify the effi cacy and safety of such products, which were already offi cialized by the Pharmacopoeia, especially those from native Brazilian plants.
MATERIAL AND METHODS
The 1 st Edition of the Pharmacopoeia (Silva, 1929) and its two supplements were searched for new data about medicinal plants and botanical products. Data concerning pharmaceutical formulations as aromatic waters, cataplasms, cigarettes, preserves, elixirs, emulsions, powders, spirits, garglings, melitos (i.e. pharmaceutical preparations containing honey), pills, potions, ointments, soaps, solutes, juices, suppositories, wines and syrups were extracted (Table 1) . Table 2 shows the pharmaceutical formulas constituted by different plant products. Among those are balsams, cerates, elixirs, plasters, emulsions, adhesive plasters, powders, spirits, extracts, fl uid extracts, liniments, oils, pills, potions, ointments, dyes, vinegars, wines and syrups. Formulas that contained chemical substances of mineral, animal or synthetic origin were not considered in the present study, except when used as vehicles.
Data about monographs for vegetal drugs (vd), tinctures (tn), fl uids extracts (fe) and resins, not included in Brandão et al. (2006) , were included in Table 1 Parts: aerial parts; balsam; bulbs; es = essential oils; exd = exsudate; fl o = fl owers; fru = fruits; gum-resin; juice; latex; lvs = leaves; oil = fi xed oil; petals; resin; rnd = rind; rts = roots; sed = seed; shoot; stm = stems; wod = wood; wpl = whole plant. Products: cataplasm; cigarette; elixir, em = emultion; es = essential oil; ex = dry extract; fe = fl uid-extract; garglings; gum; gum-resin; juice; lemonade; medicinal soap; melito; mucilage; ointment; pil = pills; potion; preserve; pulp; pw = powdered drug; resin; soap; solute; spirit; starch; supos = suppositories; syr = syrup; tn = tincture; vd = vegetal drug; water; wax; wine. 1 st Supplement, 2 2 nd Supplement Poaceae) were also included in Table 1 , since they were used exclusively as vehicle. The English names for each species and their Botanical Families were updated using data from the Missouri Botanical Garden website (www.mobot.org). For those species whose names were not found in the website, the original names described in the FBRAS were maintained.
RESULTS AND DISCUSSION
The Brazilian Pharmacopoeia is the country's offi cial pharmaceutical code, and is responsible for establishing the quality requisites for medicaments. Until the beginning of the 20 th century, the Portuguese Pharmacopoeia was adopted in Brazil as the offi cial code of medicaments. Considering the large number of products from the native Brazilian fl ora not listed in that Pharmacopoeia and which were used in the offi cial medicine at that time, such publication was not appropriated for the country's needs. The pharmacist Rodolfo A.D. Silva organized the 1 st Edition of the Pharmacopoeia, which was concluded in 1926 but only published in 1929 (Pereira, 2005; Pereira et al., 1989) . It is unnecessary to emphasize the relevance of this work, both in the past as well as in the modern days, since it correlated medicinal plants and botanical products with historical use in traditional practice and the offi cial medicine of that period. Nowadays, a Permanent Commission organizes the Brazilian Pharmacopoeia, appointed by National Health Surveillance Agency (ANVISA). This group organize reference standards and national formulary, participate in the formulation and improvement of human resources related to quality control, and support research.
Since the publication of the fi rst Edition of the FBRAS, many studies were developed in order to improve this publication. Some of them, for example, discuss better forms for data inclusion in the monographs (Barreto, 1941; Luz, 1944a Luz, , 1944b Stellfeld, 1935a; 1935b; 1935c , 1938 Luz, 1937) , modifi cation in the described methods (Angely, 1942a; 1942b; Lucas, 1942) , and the need for the inclusion of monographs for exotic medicinal plants (Costa, 1941; Luz, 1944c) , important native plants (Costa e Lucas, 1941; Cunha, 1940) , or even the removal of a product from it (Luz, 1941) . These contributions led to the publication of the fi rst and second supplements of FBRAS, in 1941 , respectively (Lucas, 1943 . Some of the monographs included in the supplements were already part of the 1 st Edition, but were improved (Stellfeld, 1947) .
In the present work we describe the results obtained in a new revision of the fi rst edition of the FBRAS and its two supplements. Quina composto Quina (fe), Calumba (fe), Cascarilha (fe), Pau Pereira (fe), Serpentária (fe), Camomila (fe), Carqueja Amarga (fe), Centaurea menor (fe), Losna (fe), Canela do Ceilão (fe) Rábano composto Cocleária (fresco), Agrião (fresca), Rábano Rústico (raiz fresca), Trevo aquático (lvs), Laranja amarga (pw), Canela do Ceilão (pw) Salsaparrilha composto Salsaparrilha (fe), Japecanga (fe), Sena (fe), Alcaçuz (fe), Anis (fe), Sassafrás (fe) Scila composto Scila (fe), Laranja amarga (fe), Quina (fe), Zimbro (fe), Casca D'Anta (fe), Losna (fe) LINIMENTS Beladona Beladona (fe), Cânfora medicinal plants and botanical products and Table 2 describes the formulations constituted by more plants and products. The use in conventional medice of several native medicinal plants was offi cialized by their inclusion on the 1 st Edition of the FBRAS. Many of those formulas were excluded from the 2 nd and 3 rd editions of FBRAS due to, among other factors, pressures from the international pharmaceutical industry, which was interested in promoting their products, specially the synthetic ones. It is possible that the preparations described in the 1 st Edition of the FBRAS present some therapeutic effi cacy, since they were used for centuries in the offi cial and traditional medicine. These plants and products need to be evaluated through pharmacological and toxicological assays (validation studies). It is also important to evaluate the combination of products in the formulations, which could result in improved pharmacologic effi cacy.
CONCLUSION
The results of this study, in association with the previous one, reveal that hundreds of medicinal species, including native ones, were offi cialized in the past through inclusion in the 1 st Edition of the FBRAS. Studies aiming at the validation of these species should be prioritized and stimulated.
